OmniAb (OABI) Change in Receivables (2022 - 2026)
OmniAb (OABI) reported Change in Receivables of $4.9 million for Q1 2026, up 947.23% year-over-year from $470000.0 in Q1 2025, and up 125.78% quarter-over-quarter from $2.2 million in Q4 2025.
OmniAb (OABI) Change in Receivables (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Change in Receivables data on file, last reported at $4.9 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $4.9 million, up 947.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 247.43% YoY), and the FY2025 annual result was -$189000.0, down 130.24% from the prior year.
- Change in Receivables advanced to $4.9 million in Q1 2026 per OABI's latest filing, from $2.2 million in the prior quarter.
- Over five years, Change in Receivables peaked at $30.3 million in Q4 2022 and troughed at -$28.8 million in Q1 2023.
- A 5-year average of -$517823.5 and a median of $230000.0 in 2025 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 1533.43% in 2023 and fell as far as 437.85% in 2023.
- A 5-year view of Change in Receivables shows it stood at $30.3 million in 2022, then slumped by 106.55% to -$2.0 million in 2023, then surged by 195.02% to $1.9 million in 2024, then increased by 15.47% to $2.2 million in 2025, then jumped by 125.78% to $4.9 million in 2026.
- Business Quant data shows OABI's Change in Receivables at $4.9 million in Q1 2026, $2.2 million in Q4 2025, and $230000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 4.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.92 Mn |
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Sep 30, 2025 | 230,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Jun 30, 2025 | -3.07 Mn |
| Jun 30, 2025 | -3.07 Mn |
| Mar 31, 2025 | 470,000.00 |
| Mar 31, 2025 | 470,000.00 |
| Dec 31, 2024 | 1.89 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | -3.86 Mn |
| Sep 30, 2024 | -3.86 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Mar 31, 2024 | -132,000.00 |
| Mar 31, 2024 | -132,000.00 |
| Dec 31, 2023 | -1.99 Mn |
| Dec 31, 2023 | -1.99 Mn |